The upregulation of NLRP3 in microglial cells leads to the release of pro‐inflammatory cytokines (such as IL‐1β and IL‐18); this in turn triggers neuroinflammation and neuronal damage, which contributes to the onset and progression of depression [20]. The gene discussed is NLRP3; the disease is depressive symptom measurement.